explore -WSS

explore

author：explore 2025-09-27 22:48:46 - browse：95472

Perrigo Opill press photo – pharma coverage from STAT — Opill, the first over-the-counter birth control pill, is on its way to U.S. stores. Perrigo via AP

WASHINGTON — The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin.

Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price. It will also be sold online.

The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription. Ireland-based Perrigo noted there will be no age restrictions on sales, similar to other over-the-counter medications.

Opill is an older class of contraceptive, sometimes called minipills, that contain a single synthetic hormone, progestin, and generally carry fewer side effects than more popular combination estrogen and progestin pills.

Newsletters

Sign up for Morning Rounds

Understand how science, health policy, and medicine shape the world every day

Please enter a valid email address. Privacy Policy

The launch gives U.S. women another birth control option amid the legal and political battles over reproductive health, including the reversal of Roe v. Wade, which has upended abortion access across the U.S. Opill’s approval is unrelated to the ongoing court battles over the abortion pill mifepristone. And anti-abortion groups have generally emphasized that they do not oppose contraceptives to prevent pregnancies.

Birth control pills are available without a prescription across much of South America, Asia, and Africa.

The drug’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain medical conditions would understand that they shouldn’t take the drug.

Dr. Verda Hicks, president of the American College of Obstetricians and Gynecologists, in a statement, said studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.

— Matthew Perrone

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Wikipedia

WSS

NYU Langone launches private ChatGPT for its health care data

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

What do new weight loss drugs mean for bariatric surgery?

Xenotransplantation trials will require adjusting expectations, experts say

What AAP's gender

hotspot

explore

Sign up for Morning Rounds

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

As pharma fights Medicare drug negotiation, hospitals, docs silent

In age of alternative facts, a scholarly course on calling out crap

In science, is the line between industry and academia shifting?

Walensky prepares to leave CDC — and Congress — behind

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

How to save PrEP access — and even expand it

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Medicare proposal to cover medical devices draws a mixed reaction

Reanimated hearts work just as well for transplants, study finds

leisure time

Australia’s approach to dialysis celebrates life

Patients, doctors are clashing about side effects of hormonal birth control

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Timeline: Key moments in fight for gay rights

Novo: Oral version of Ozempic leads to 15% weight loss

2024 GOP presidential candidates spar over abortion in debate

knowledge

focus

Wikipedia

explore